Table 1 Novel POU4F3 variants in the current study and in-silico prediction analysis
Proband | Genomic position: change (GRCh37/hg19) | HGVS | Location (exon/domain) | Zygosity/inheritance | Insilico predictions | Alternative allele frequency | ACMG/AMP 2018 guideline | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Nucleotide change | Amino acid change | CADD Phred | REVEL | KRGDB (1722 individuals) | GMAF (gnomAD) | Criteria | Classification | ||||
SB218-423 | Chr5:145719554A>AA | c.564dupA | p.Ala189SerfsTer26 | Exon2/POU | Het/autosomal dominant | NA | NA | Absent | Absent | PVS1, PM2, PS3_supporting | Pathogenic |
SB307-610 | Chr5:145719733T>C | c.743T>C | p.Leu248Pro | Exon2/POU | Het/autosomal dominant | 29.3 | 0.950 | Absent | Absent | PM2, PP3, PS3_supporting | VUS |
SB438-852 | Chr5:145719869C>G | c.879C>A | p.Phe293Leu | Exon2/homeobox | Het/autosomal dominant | 24.8 | 0.913 | Absent | Absent | PM2, PP3, PS3_supporting | VUS |
SB347-679 | Chr5:145719942G>A | c.952G>A | p.Val318Met | Exon2/homeobox | Het/autosomal dominant | 29.6 | 0.936 | Absent | Absent | PM2, PP3, PS3_supporting | VUS |